M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Accounts Receivables
zł422.8k
CAGR 3-Years
248%
CAGR 5-Years
43%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Accounts Receivables
zł665k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Accounts Receivables
zł12.4m
CAGR 3-Years
175%
CAGR 5-Years
N/A
CAGR 10-Years
7%
S
Selvita SA
WSE:SLV
Accounts Receivables
zł72.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Accounts Receivables?
Accounts Receivables
422.8k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Accounts Receivables amounts to 422.8k PLN.

What is Medicofarma Biotech SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
43%

Over the last year, the Accounts Receivables growth was 0%. The average annual Accounts Receivables growth rates for Medicofarma Biotech SA have been 248% over the past three years , 43% over the past five years .

Back to Top